Ravicti Alternatives Compared
| Ravicti (glycerol phenylbutyrate) | Buphenyl (sodium phenylbutyrate) | Sodium phenylbutyrate |
|
|---|
| Ravicti (glycerol phenylbutyrate) | Buphenyl (sodium phenylbutyrate) | Sodium phenylbutyrate |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Urea Cycle Disorders. Ravicti may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Urea Cycle Disorders. Buphenyl may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Urea Cycle Disorders. Sodium phenylbutyrate may also be used for purposes not listed in this medication guide. |
Related suggestions Urea Cycle Disorders
Popular comparisons
|
|||||||||||||||||||||||
| More about Ravicti (glycerol phenylbutyrate) | More about Buphenyl (sodium phenylbutyrate) | More about Sodium phenylbutyrate | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Ravicti prices |
View all Buphenyl prices |
View all Sodium phenylbutyrate prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
Other sodium phenylbutyrate brands include: Olpruva, Pheburane | Buphenyl, Olpruva, Pheburane | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 267 drugs are known to interact with Ravicti:
|
A total of 32 drugs are known to interact with Buphenyl:
|
A total of 32 drugs are known to interact with Sodium phenylbutyrate:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
February 01, 2013 |
May 13, 1996 |
May 13, 1996 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.